Literature DB >> 30519951

Computational Analyses Connect Small-Molecule Sensitivity to Cellular Features Using Large Panels of Cancer Cell Lines.

Matthew G Rees1, Brinton Seashore-Ludlow2, Paul A Clemons3.   

Abstract

We recently pioneered several analyses of small-molecule sensitivity data collected from large-scale perturbation of hundreds of cancer cell lines with hundreds of small molecules, with cell viability measured as a readout of compound sensitivity. We performed these studies using cancer cell lines previously annotated with cellular, genomic, and basal gene-expression features. By combining small-molecule sensitivity data with these other datasets, we identified new candidate biomarkers of sensitivity, gained insights into small-molecule mechanisms of action, and proposed candidate hypotheses for cancer dependencies (including candidate combination therapies). Nevertheless, given the size of these datasets, we expect that many connections between cellular features and small-molecule sensitivity remain underexplored. In this chapter, we provide a step-by-step account of foundational data-analysis methods underlying our published studies, including working MATLAB code applied to our own public datasets. These procedures will allow others to repeat analyses of our data with new parameters, in additional contexts, and to adapt our procedures to their own datasets.

Entities:  

Keywords:  Biomarkers; Cancer dependencies; Chemical biology; Combination therapy; Computational biology; Data sharing; Pharmacogenomics; Public datasets; Reproducibility

Mesh:

Substances:

Year:  2019        PMID: 30519951      PMCID: PMC6563933          DOI: 10.1007/978-1-4939-8891-4_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  37 in total

1.  An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.

Authors:  Amrita Basu; Nicole E Bodycombe; Jaime H Cheah; Edmund V Price; Ke Liu; Giannina I Schaefer; Richard Y Ebright; Michelle L Stewart; Daisuke Ito; Stephanie Wang; Abigail L Bracha; Ted Liefeld; Mathias Wawer; Joshua C Gilbert; Andrew J Wilson; Nicolas Stransky; Gregory V Kryukov; Vlado Dancik; Jordi Barretina; Levi A Garraway; C Suk-Yee Hon; Benito Munoz; Joshua A Bittker; Brent R Stockwell; Dineo Khabele; Andrew M Stern; Paul A Clemons; Alykhan F Shamji; Stuart L Schreiber
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

2.  Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.

Authors:  E Robert McDonald; Antoine de Weck; Michael R Schlabach; Eric Billy; Konstantinos J Mavrakis; Gregory R Hoffman; Dhiren Belur; Deborah Castelletti; Elizabeth Frias; Kalyani Gampa; Javad Golji; Iris Kao; Li Li; Philippe Megel; Thomas A Perkins; Nadire Ramadan; David A Ruddy; Serena J Silver; Sosathya Sovath; Mark Stump; Odile Weber; Roland Widmer; Jianjun Yu; Kristine Yu; Yingzi Yue; Dorothee Abramowski; Elizabeth Ackley; Rosemary Barrett; Joel Berger; Julie L Bernard; Rebecca Billig; Saskia M Brachmann; Frank Buxton; Roger Caothien; Justina X Caushi; Franklin S Chung; Marta Cortés-Cros; Rosalie S deBeaumont; Clara Delaunay; Aurore Desplat; William Duong; Donald A Dwoske; Richard S Eldridge; Ali Farsidjani; Fei Feng; JiaJia Feng; Daisy Flemming; William Forrester; Giorgio G Galli; Zhenhai Gao; François Gauter; Veronica Gibaja; Kristy Haas; Marc Hattenberger; Tami Hood; Kristen E Hurov; Zainab Jagani; Mathias Jenal; Jennifer A Johnson; Michael D Jones; Avnish Kapoor; Joshua Korn; Jilin Liu; Qiumei Liu; Shumei Liu; Yue Liu; Alice T Loo; Kaitlin J Macchi; Typhaine Martin; Gregory McAllister; Amandine Meyer; Sandra Mollé; Raymond A Pagliarini; Tanushree Phadke; Brian Repko; Tanja Schouwey; Frances Shanahan; Qiong Shen; Christelle Stamm; Christine Stephan; Volker M Stucke; Ralph Tiedt; Malini Varadarajan; Kavitha Venkatesan; Alberto C Vitari; Marco Wallroth; Jan Weiler; Jing Zhang; Craig Mickanin; Vic E Myer; Jeffery A Porter; Albert Lai; Hans Bitter; Emma Lees; Nicholas Keen; Audrey Kauffmann; Frank Stegmeier; Francesco Hofmann; Tobias Schmelzle; William R Sellers
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

3.  Revisiting inconsistency in large pharmacogenomic studies.

Authors:  Zhaleh Safikhani; Petr Smirnov; Mark Freeman; Nehme El-Hachem; Adrian She; Quevedo Rene; Anna Goldenberg; Nicolai J Birkbak; Christos Hatzis; Leming Shi; Andrew H Beck; Hugo J W L Aerts; John Quackenbush; Benjamin Haibe-Kains
Journal:  F1000Res       Date:  2016-09-16

4.  Inconsistency in large pharmacogenomic studies.

Authors:  Benjamin Haibe-Kains; Nehme El-Hachem; Nicolai Juul Birkbak; Andrew C Jin; Andrew H Beck; Hugo J W L Aerts; John Quackenbush
Journal:  Nature       Date:  2013-11-27       Impact factor: 49.962

5.  Connecting Small Molecules with Similar Assay Performance Profiles Leads to New Biological Hypotheses.

Authors:  Vlado Dančík; Hyman Carrel; Nicole E Bodycombe; Kathleen Petri Seiler; Dina Fomina-Yadlin; Stefan T Kubicek; Kimberly Hartwell; Alykhan F Shamji; Bridget K Wagner; Paul A Clemons
Journal:  J Biomol Screen       Date:  2014-01-24

6.  Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.

Authors:  Vasanthi S Viswanathan; Matthew J Ryan; Harshil D Dhruv; Shubhroz Gill; Ossia M Eichhoff; Brinton Seashore-Ludlow; Samuel D Kaffenberger; John K Eaton; Kenichi Shimada; Andrew J Aguirre; Srinivas R Viswanathan; Shrikanta Chattopadhyay; Pablo Tamayo; Wan Seok Yang; Matthew G Rees; Sixun Chen; Zarko V Boskovic; Sarah Javaid; Cherrie Huang; Xiaoyun Wu; Yuen-Yi Tseng; Elisabeth M Roider; Dong Gao; James M Cleary; Brian M Wolpin; Jill P Mesirov; Daniel A Haber; Jeffrey A Engelman; Jesse S Boehm; Joanne D Kotz; Cindy S Hon; Yu Chen; William C Hahn; Mitchell P Levesque; John G Doench; Michael E Berens; Alykhan F Shamji; Paul A Clemons; Brent R Stockwell; Stuart L Schreiber
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

7.  A Landscape of Pharmacogenomic Interactions in Cancer.

Authors:  Francesco Iorio; Theo A Knijnenburg; Daniel J Vis; Graham R Bignell; Michael P Menden; Michael Schubert; Nanne Aben; Emanuel Gonçalves; Syd Barthorpe; Howard Lightfoot; Thomas Cokelaer; Patricia Greninger; Ewald van Dyk; Han Chang; Heshani de Silva; Holger Heyn; Xianming Deng; Regina K Egan; Qingsong Liu; Tatiana Mironenko; Xeni Mitropoulos; Laura Richardson; Jinhua Wang; Tinghu Zhang; Sebastian Moran; Sergi Sayols; Maryam Soleimani; David Tamborero; Nuria Lopez-Bigas; Petra Ross-Macdonald; Manel Esteller; Nathanael S Gray; Daniel A Haber; Michael R Stratton; Cyril H Benes; Lodewyk F A Wessels; Julio Saez-Rodriguez; Ultan McDermott; Mathew J Garnett
Journal:  Cell       Date:  2016-07-07       Impact factor: 41.582

8.  GDSCTools for mining pharmacogenomic interactions in cancer.

Authors:  Thomas Cokelaer; Elisabeth Chen; Francesco Iorio; Michael P Menden; Howard Lightfoot; Julio Saez-Rodriguez; Mathew J Garnett
Journal:  Bioinformatics       Date:  2018-04-01       Impact factor: 6.937

9.  TCPA: a resource for cancer functional proteomics data.

Authors:  Jun Li; Yiling Lu; Rehan Akbani; Zhenlin Ju; Paul L Roebuck; Wenbin Liu; Ji-Yeon Yang; Bradley M Broom; Roeland G W Verhaak; David W Kane; Chris Wakefield; John N Weinstein; Gordon B Mills; Han Liang
Journal:  Nat Methods       Date:  2013-09-15       Impact factor: 28.547

10.  SAMHD1 protects cancer cells from various nucleoside-based antimetabolites.

Authors:  Nikolas Herold; Sean G Rudd; Kumar Sanjiv; Juliane Kutzner; Julia Bladh; Cynthia B J Paulin; Thomas Helleday; Jan-Inge Henter; Torsten Schaller
Journal:  Cell Cycle       Date:  2017-04-24       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.